Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.51703 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.4946 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.50748 | 21 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.4492 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.44257 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.56908 | 21 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.53171 | 21 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.47603 | 21 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46874 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.61509 | 27 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.48765 | 21 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.47478 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.48771 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49357 | 21 |